CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2023, as well as key clinical and corporate developments.
Clinical and Corporate Developments:
CEL-SCI.
CEL-SCI Corporation today reported financial results for the quarter ended June 30, 2023, as well as key clinical and corporate developments.
Clinical and Corporate Developments this quarter.
Coexisting conditions impact survival in oral cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.